MUSTANG BIO INC's ticker is MBIO and the CUSIP is 62818Q104. A total of 78 filers reported holding MUSTANG BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $102 | +7.4% | 278,906 | +15.4% | 0.00% | – |
Q4 2022 | $95 | -99.9% | 241,757 | -22.8% | 0.00% | – |
Q3 2022 | $147,000 | -60.9% | 313,264 | -51.3% | 0.00% | – |
Q2 2022 | $376,000 | +2250.0% | 643,231 | +3861.8% | 0.00% | – |
Q1 2022 | $16,000 | -98.5% | 16,236 | -97.4% | 0.00% | -100.0% |
Q4 2021 | $1,043,000 | -40.7% | 628,193 | -4.0% | 0.00% | 0.0% |
Q3 2021 | $1,760,000 | -18.5% | 654,152 | +0.6% | 0.00% | 0.0% |
Q2 2021 | $2,160,000 | -48.4% | 650,453 | -48.4% | 0.00% | -66.7% |
Q1 2021 | $4,187,000 | -41.8% | 1,261,021 | -33.7% | 0.00% | -40.0% |
Q4 2020 | $7,197,000 | +57.6% | 1,901,389 | +31.1% | 0.01% | -16.7% |
Q3 2020 | $4,567,000 | +81.1% | 1,449,937 | +82.8% | 0.01% | +100.0% |
Q2 2020 | $2,522,000 | +2938.6% | 793,182 | +2453.1% | 0.00% | – |
Q1 2020 | $83,000 | +72.9% | 31,068 | +162.1% | 0.00% | – |
Q4 2019 | $48,000 | -49.5% | 11,852 | -59.5% | 0.00% | – |
Q3 2019 | $95,000 | -91.4% | 29,288 | -71.0% | 0.00% | -100.0% |
Q1 2018 | $1,105,000 | +239.0% | 101,029 | +271.7% | 0.00% | – |
Q4 2017 | $326,000 | – | 27,179 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Telemetry Investments, L.L.C. | 297,500 | $300,000 | 0.47% |
GSA CAPITAL PARTNERS LLP | 1,216,445 | $1,229,000 | 0.16% |
Ikarian Capital, LLC | 546,824 | $551,000 | 0.07% |
Sassicaia Capital Advisers LLC | 12,000 | $12,000 | 0.06% |
EMFO, LLC | 32,000 | $32,000 | 0.03% |
B. Riley Wealth Advisors, Inc. | 310,926 | $315,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 312,800 | $316,000 | 0.01% |
Renaissance Technologies | 2,449,100 | $2,474,000 | 0.00% |
Arete Wealth Advisors, LLC | 15,538 | $16,000 | 0.00% |
Herold Advisors, Inc. | 4,000 | $4,040,000 | 0.00% |